Contract with Customer, Liability, Current in USD of ImmunoGen, Inc. from Q4 2017 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
ImmunoGen, Inc. quarterly Contract with Customer, Liability, Current history and change rate from Q4 2017 to Q3 2023.
  • ImmunoGen, Inc. Contract with Customer, Liability, Current for the quarter ending 30 Sep 2023 was $37.2M, a 147% increase year-over-year.
Contract with Customer, Liability, Current, Quarterly (USD)
Contract with Customer, Liability, Current, YoY Quarterly Change (%)

ImmunoGen, Inc. Quarterly Contract with Customer, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2023 $37.2M +$22.1M +147% 30 Sep 2023 10-Q 02 Nov 2023
Q2 2023 $14.4M -$1.25M -7.98% 30 Jun 2023 10-Q 31 Jul 2023
Q1 2023 $13.4M -$9.97M -42.6% 31 Mar 2023 10-Q 28 Apr 2023
Q4 2022 $13.9M -$30.5M -68.8% 31 Dec 2022 10-Q 02 Nov 2023
Q3 2022 $15.1M -$38.4M -71.8% 30 Sep 2022 10-Q 04 Nov 2022
Q2 2022 $15.6M -$38.2M -70.9% 30 Jun 2022 10-Q 01 Aug 2022
Q1 2022 $23.4M -$28.1M -54.5% 31 Mar 2022 10-Q 06 May 2022
Q4 2021 $44.4M +$15.1M +51.6% 31 Dec 2021 10-K 01 Mar 2023
Q3 2021 $53.5M +$49.5M +1243% 30 Sep 2021 10-Q 29 Oct 2021
Q2 2021 $53.8M +$53.7M +67140% 30 Jun 2021 10-Q 30 Jul 2021
Q1 2021 $51.5M +$51.4M +41782% 31 Mar 2021 10-Q 10 May 2021
Q4 2020 $29.2M +$28.9M +9366% 31 Dec 2020 10-K 28 Feb 2022
Q3 2020 $3.99M -$10.8M -73.1% 30 Sep 2020 10-Q 06 Nov 2020
Q2 2020 $80K -$237K -74.8% 30 Jun 2020 10-Q 05 Aug 2020
Q1 2020 $123K -$194K -61.2% 31 Mar 2020 10-Q 05 May 2020
Q4 2019 $309K -$8K -2.52% 31 Dec 2019 10-K 01 Mar 2021
Q3 2019 $14.8M +$13.1M +765% 30 Sep 2019 10-Q 05 Nov 2019
Q2 2019 $317K -$703K -68.9% 30 Jun 2019 10-Q 07 Aug 2019
Q1 2019 $317K -$294K -48.1% 31 Mar 2019 10-Q 07 May 2019
Q4 2018 $317K -$1.09M -77.4% 31 Dec 2018 10-K 11 Mar 2020
Q3 2018 $1.71M 30 Sep 2018 10-Q 02 Nov 2018
Q2 2018 $1.02M 30 Jun 2018 10-Q 03 Aug 2018
Q1 2018 $611K 31 Mar 2018 10-Q 09 May 2018
Q4 2017 $1.41M 31 Dec 2017 10-K 01 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.